SKI Market

Indian Indices

Nifty

22,403.85 203.30
(0.92%)

Sensex

73,663.72 676.69
( 0.93%)

Bank Nifty

47,977.05 289.60
( 0.61%)

Nifty IT

33,668.45 551.05
( 1.66%)

Global Indices

Nasdaq

16,742.39 231.21
(1.40%)

Dow Jones

39,908.00 349.89
(0.88%)

Hang Seng

19,376.53 302.82
(1.59%)

Nikkei 225

38,920.26 534.53
(1.39%)

Forex

USD-INR

83.51 -0.01
(-0.01%)

EUR-INR

90.20 0.14
(0.16%)

GBP-INR

104.93 0.20
(0.19%)

JPY-INR

0.53 0.00
(-0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fermenta Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506414

INE225B01021

105.2575279

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

480.46

EPS(TTM)

Face Value()

Div & Yield %

3.08

0.75

Back

dil ltd

Fermenta Biotech reports consolidated net profit of Rs 9.85 crore in the December 2023 quarter

Feb 12,2024

Net profit of Fermenta Biotech reported to Rs 9.85 crore in the quarter ended December 2023 as against net loss of Rs 37.39 crore during the previous quarter ended December 2022. Sales rose 80.40% to Rs 98.97 crore in the quarter ended December 2023 as against Rs 54.86 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	98.97	54.86	80
OPM %	25.38	-17.90	-
PBDT	22.46	-14.96	LP
PBT	16.07	-21.29	LP
NP	9.85	-37.39	LP

22,403.85 203.30 (0.92%)

73,663.72 676.69 ( 0.93%)

47,977.05 289.60 ( 0.61%)

33,668.45 551.05 ( 1.66%)

16,742.39 231.21 (1.40%)

39,908.00 349.89 (0.88%)

19,376.53 302.82 (1.59%)

38,920.26 534.53 (1.39%)

83.51 -0.01 (-0.01%)

90.20 0.14 (0.16%)

104.93 0.20 (0.19%)

0.53 0.00 (-0.30%)